← Back to Clinical Trials
Recruiting NCT06691750

NCT06691750 Clinical Impact of Uterine Repair During Cesarean Section with Barbed Suture on the Incidence of Isthmocele

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06691750
Status Recruiting
Phase
Sponsor Hospital Clinic of Barcelona
Condition Isthmocele
Study Type INTERVENTIONAL
Enrollment 364 participants
Start Date 2024-11-22
Primary Completion 2027-11

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Barbed sutureConventional smooth suture

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 364 participants in total. It began in 2024-11-22 with a primary completion date of 2027-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pregnant women, irrespective of their pregnancy risk, who undergo a cesarean section for any reason will be randomized to one of two suturing techniques: conventional suture or barbed suture for uterine repair after the cesarean section. Following surgery, these patients will be followed up for clinical outcomes, ultrasound evaluation of the uterine scar, and study of the hypoxic-inflammatory environment of the uterine cavity.

Eligibility Criteria

Inclusion Criteria: * Pregnant women who deliver at Hospital Clinic of Barcelona by a planned, intrapartum or urgent cesarean section, irrespective of their pregnancy risk. * Had accepted to participate in the study during the third trimester of gestation. * Patients who accept a 6-month follow-up visit. * Minimal maternal age of 18 years old. Exclusion Criteria: * Patients who end up delivering in another center. * Patients who deliver by vaginal route. * Patients diagnosed with isthmocele prior to the current pregnancy. * Need for histerectomy in the following 6 months after delivery. * Patients with known allergies to any of the components of the barbed suture.

Contact & Investigator

Central Contact

Cristina Mula

✉ mula@clinic.cat

📞 +34 635486919

Frequently Asked Questions

Who can join the NCT06691750 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Isthmocele. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06691750 currently recruiting?

Yes, NCT06691750 is actively recruiting participants. Contact the research team at mula@clinic.cat for enrollment information.

Where is the NCT06691750 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT06691750 clinical trial?

NCT06691750 is sponsored by Hospital Clinic of Barcelona. The trial plans to enroll 364 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology